Srini Tenjarla - Jul 15, 2024 Form 4 Insider Report for Serina Therapeutics, Inc. (SER)

Role
SVP, CMC & Formulation
Signature
/s/ Srini Tenjarla
Stock symbol
SER
Transactions as of
Jul 15, 2024
Transactions value $
$0
Form type
4
Date filed
7/17/2024, 05:10 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SER Stock Option (right to buy) Award $0 +185K $0.00 185K Jul 15, 2024 Common Stock 185K $9.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options vest as to 61,666 of the underlying shares on July 15, 2025, and thereafter in substantially equal installments such that the stock options shall be fully vested on the third anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.